MINNEAPOLIS, MN — January 10, 2025 (PR Newswire) Saluda Medical, Inc., a commercial-stage medical device company focused on development treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform, today announced the closing of a $100 million financing. FLG Managing Partner Laureen DeBuono assisted as Board of Directors…Read More
“We brought on FLG Partners to assess our accounting and finance infrastructure, processes and team. Frank Tsaihas a great deal of non-profit experience and quickly provided us with a series of areas to focus on to reduce cost and improve process. He identified ways to increase internal controls and reduce redundancies. He prioritized the financial leadership skills we needed in our financial team to upgrade our accounting and financial systems. Implementing Frank’s recommendations had a major impact on our organization and ultimately led to a complete restructuring of our finance department. Frank’s assessment work would help any organization seeking to optimize systems, increase effectiveness and scale infrastructure.”
